Related Experiment Video

Updated: Apr 8, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

9.5K

Grb2 monomer-dimer equilibrium determines normal versus oncogenic function

Zamal Ahmed1, Zahra Timsah2, Kin M Suen2

  • 11] Department of Biochemistry and Molecular Biology, University of Texas, M.D. Anderson Cancer Center, Unit 1000, 1515 Holcombe Boulevard, Houston, Texas 77030, USA [2] Center for Biomolecular Structure and Function, University of Texas, M.D. Anderson Cancer Center, Unit 1000, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.

Nature Communications
|June 25, 2015
PubMed

Insights

Monomeric growth factor receptor-bound protein 2 (Grb2) activates Ras/MAP kinase signaling, while its dimeric form inhibits it. Phosphorylation or ligand binding dissociates Grb2 dimers, impacting cancer progression.

Area of Science:

  • Cellular signaling
  • Molecular biology
  • Cancer research

Background:

  • Growth factor receptor-bound protein 2 (Grb2) is a key adaptor protein in eukaryotic intracellular signaling.
  • Grb2 links receptor tyrosine kinases to the Ras/MAP kinase pathway, crucial for cell growth and implicated in cancer.
  • Grb2 exists in a dynamic equilibrium between monomeric and dimeric states.

Purpose of the Study:

  • To investigate the role of Grb2's monomeric and dimeric states in regulating MAP kinase signaling.
  • To determine the mechanism by which Grb2 self-association/dissociation influences signaling pathways.
  • To explore the relevance of Grb2 dimerization in human cancers.

Main Methods:

  • Analysis of Grb2 protein interactions and states (monomeric vs. dimeric).
  • Investigation of Grb2 binding to SOS and its effect on MAP kinase pathway activation.
  • Examination of tyrosine 160 (Y160) phosphorylation and its impact on Grb2 dimerization.
  • Detection of Y160 phosphorylation in clinical cancer samples.

Main Results:

  • Only monomeric Grb2 effectively binds to SOS and upregulates MAP kinase signaling.
  • The dimeric state of Grb2 inhibits MAP kinase signaling.
  • Phosphorylation of Grb2 at Y160 or SH2 domain ligand binding induces dimer dissociation.
  • Y160 phosphorylation is prevalent in malignant prostate, colon, and breast cancers.

Conclusions:

  • Grb2 self-association/dissociation acts as a molecular switch controlling MAP kinase activity.
  • This switch mechanism is critical for regulating cancer progression.
  • Targeting Grb2 dimerization could offer novel therapeutic strategies for cancer treatment.

More Related Videos

Oligomerization Dynamics of Cell Surface Receptors in Living Cells by Total Internal Reflection Fluorescence Microscopy Combined with Number and Brightness Analysis10:43

Oligomerization Dynamics of Cell Surface Receptors in Living Cells by Total Internal Reflection Fluorescence Microscopy Combined with Number and Brightness Analysis

Published on: November 6, 2019

7.4K
A High-content Imaging Workflow to Study Grb2 Signaling Complexes by Expression Cloning10:52

A High-content Imaging Workflow to Study Grb2 Signaling Complexes by Expression Cloning

Published on: October 30, 2012

11.2K

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.0K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
3.5K